Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in Austria / NCT06803615
Active, not recruiting Observational

Noninvasive Mapping Before Surgical Ablation

NCT06803615 · tracked via the Priya Life Science Austria tracker
Sponsor
Medical University of Vienna
Phase
Observational
Started
2017-01-13
Last updated
2025-06-29

Condition(s) studied

Atrial Fibrillation (AF)

Investigational drug(s) / intervention(s)

Electrocardiographic imaging

Electrocardiographic imaging: Electrocardiographic imaging is an electrophysiological mapping technique which is used to noninvasively map cardiac arrhythmias.

Study summary

The purpose of this study is to assess the electrophysiological mechanism of atrial fibrillation by means of a beat-to-beat noninvasive 3D mapping method in patients with concomitant persistent and long-standing persistent atrial fibrillation undergoing surgical ablation.

Eligibility

Sex
ALL
Min age
18 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria: * legal age (18-90a) * life expectancy \> 2 years * patients suffering from persistent and long standing atrial fibrillation * scheduled for concomitant surgical ablation * possibility to follow-up * given informed consent Exclusion Criteria: * vulnerable patient groups * pregnancy * any previous surgical ablation * acute surgical indications * any physical condition that leads to a life expectancy of less than two years * any contraindication to the treatments necessary for the trial's conduction as e.g. * known allergic reaction to contrast agent * known allergic reaction to antiarrhythmic drugs * claustrophobia or anxiety in small spaces * severe renal impairment * unmanageable hyperthyroidism * participation in any other clinical trial that either excludes enrolment or may be a confounding factor to results * voluntary retention

Primary outcome measure(s)

  • The patients electrophysiological mapping results acquired with ECGI will be analyzed: Number and distribution of rotor and focal activities will be measured. — Prior to the planned procedure.
    The primary objective of this study is to measure the patients electrophysiological mapping results acquired with ECGI, namely the number and distribution of focal and rotor activities.

Trial sites (1)

FacilityCityRegionStatus
Medical University of Vienna Vienna Austria

More Medical University of Vienna trials in Austria

Quality of Life of Periodontitis Patients Visiting Supportive Periodontal Therapy Recruiting
Edge-to-edge Mitral Valve Repair in ATTR-CM Recruiting
Ketamine in OCD: Efficacy and Effects on Stress and Cognition Recruiting
Measurement of Ocular Blood Flow and Retinal Oxygen Extraction in Diabetic Patients Recruiting
LETHE-AT: a Personalized Multidomain Lifestyle Intervention for Individuals at Increased Risk of Memory Impairment. Starting soon

Other trials for the same condition

CATCH AF - Atrial Fibrillation Detection in Cryptogenic Stroke Starting soon
Comparison of 7-Day ECG Patches Active, not recruiting
FARAPULSE Workflow Assessment Registry Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06803615 on ClinicalTrials.gov ↗ ← All trials in Austria